Log In
Print
BCIQ
Print
Print this Print this
 

Hemangeol, Hemangiol, propranolol

  Manage Alerts
Collapse Summary General Information
Company Laboratoires Pierre Fabre S.A.
DescriptionPediatric formulation of propranolol, a non-selective adrenergic receptor beta (ADRB) blocker
Molecular Target Adrenergic receptor beta (ADRB)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard Indication Cancer (unspecified)
Indication DetailsTreat infantile hemangiomas
Regulatory Designation

EU - Standard Review (Treat infantile hemangiomas);
Japan - Orphan Drug (Treat infantile hemangiomas);
Australia - Orphan Drug (Treat infantile hemangiomas)

Partner

Maruho Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today